Ana Luisa Bagno de Almeida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ana Luisa Bagno de Almeida has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Alisson Pugliesi
Departamento de Reumatologia, Universidade Estadual de Campinas, Campinas, Brazil
1 shared publicationAna Paula Monteiro Gomides Reis
Departamento de Reumatologia, Universidade de Brasília, Brasília, Brazil
1 shared publicationClaiton Viegas Brenol
Departamento de Reumatologia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
1 shared publication- Eliane Viana Mancuzo
Federal University of Minas Gerais, Belo Horizonte, Brazil
1 shared publication Geraldo da Rocha Castelar-Pinheiro
Departamento de Reumatologia, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil
1 shared publicationGláucio Ricardo Werner de Castro
Departamento de Reumatologia, Universidade do Sul de Santa Catarina-Unisul, Florianópolis, Brazil
1 shared publication
Latest Publications
- Open Access
- 3 July 2025
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 51 (4) , e20240402
Evaluation of screening methods for preclinical interstitial lung disease associat-ed with rheumatoid arthritis
- 3 July 2025
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 51 (4) , e20240402
Open AccessEvaluation of screening methods for preclinical interstitial lung disease associat-ed with rheumatoid arthritis
- Open Access
- 29 March 2024
- Published by Springer Nature in Advances in Rheumatology
- Vol. 64 (1) , 1-8
Predictors of serious infections in rheumatoid arthritis—a prospective Brazilian cohort
Background: Infections increase mortality and morbidity and often limit immunosuppressive treatment in rheumatoid arthritis patients. Objective: To analyze the occurrence of serious infections and the associated factors in a cohort of rheumatoid arthritis patients under real-life conditions. Methods: We analyzed data from the REAL, a prospective observational study, that evaluated Brazilian RA patients, with clinical and laboratory data collected over a year. Univariate and multivariate analyses were performed from the adjustment of the logistic regression model Generalized Estimating Equations (GEE), with the primary outcome being the occurrence of serious infection, defined as need for hospitalization or use of intravenous antibiotics for its treatment. Results: 841 patients were included with an average follow-up time of 11.2 months (SD 2.4). Eighty-nine serious infections occurred, corresponding to 13 infections per 100 patient-years. Pulmonary fibrosis, chronic kidney disease (CKD) and central nervous system disease increased the chances of serious infection by 3.2 times (95% CI: 1.5–6.9), 3.6 times (95% CI: 1.2–10.4) and 2.4 times (95% CI: 1.2–5.0), respectively. The use of corticosteroids in moderate doses increased the chances by 5.4 times (95% CI: 2.3–12.4), and for each increase of 1 unit in the health assessment questionnaire (HAQ), the chance increased 60% (95% CI: 20–120%). Conclusion: The use of corticosteroids at moderate doses increased the risk of serious infection in RA patients. Reduced functionality assessed by the HAQ and comorbidities were other important factors associated with serious infection in this cohort.
- 29 March 2024
- Published by Springer Nature in Advances in Rheumatology
- Vol. 64 (1) , 1-8
Open AccessPredictors of serious infections in rheumatoid arthritis—a prospective Brazilian cohort
Background: Infections increase mortality and morbidity and often limit immunosuppressive treatment in rheumatoid arthritis patients. Objective: To analyze the occurrence of serious infections and the associated factors in a cohort of rheumatoid arthritis patients under real-life conditions. Methods: We analyzed data from the REAL, a prospective observational study, that evaluated Brazilian RA patients, with clinical and laboratory data collected over a year. Univariate and multivariate analyses were performed from the adjustment of the logistic regression model Generalized Estimating Equations (GEE), with the primary outcome being the occurrence of serious infection, defined as need for hospitalization or use of intravenous antibiotics for its treatment. Results: 841 patients were included with an average follow-up time of 11.2 months (SD 2.4). Eighty-nine serious infections occurred, corresponding to 13 infections per 100 patient-years. Pulmonary fibrosis, chronic kidney disease (CKD) and central nervous system disease increased the chances of serious infection by 3.2 times (95% CI: 1.5–6.9), 3.6 times (95% CI: 1.2–10.4) and 2.4 times (95% CI: 1.2–5.0), respectively. The use of corticosteroids in moderate doses increased the chances by 5.4 times (95% CI: 2.3–12.4), and for each increase of 1 unit in the health assessment questionnaire (HAQ), the chance increased 60% (95% CI: 20–120%). Conclusion: The use of corticosteroids at moderate doses increased the risk of serious infection in RA patients. Reduced functionality assessed by the HAQ and comorbidities were other important factors associated with serious infection in this cohort.